Cabergolina versus bromocriptina en el tratamiento de la hiperprolactinemia: una revisión sistemática de ensayos controlados aleatorios y meta-análisis

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2012
Cargando información sobre las referencias

CRD SUMMARY:

The review found cabergoline was significantly more effective than bromocriptine in normalising prolactin level, reducing persistent amenorrhoea, menses normalisation and returning normal ovulatory cycles in treatment of prolactinomas and idiopathic hyperprolactinaemia. Cabergoline also had significantly fewer adverse events. Substantial differences between studies for the main outcome and relatively low patient numbers make the reliability of the authors’ conclusions unclear.
Epistemonikos ID: 68f455b571a75ce1200376865c64d75c7b342431
First added on: Jan 13, 2015